ADELMAN JASON T 4
Research Summary
AI-generated summary
Trio-Tech (TRT) Director Jason Adelman Exercises Options, Sells Shares
What Happened
- Jason T. Adelman, a director of Trio-Tech International (TRT), exercised stock options for 39,750 shares at $2.25 per share (cost ≈ $89,438) on May 18, 2026.
- The Form 4 shows a simultaneous derivative disposition of 39,750 shares at $0 (often used to satisfy exercise costs or tax withholding) and multiple open-market sales totaling 49,975 shares across May 18–19, 2026, generating about $818,325 in gross proceeds.
- This sequence combines an option exercise (acquisition) with substantial share sales (liquidity-taking). Exercises are technically purchases; the subsequent sales are routine insider disposals.
Key Details
- Transaction dates and prices:
- 2026-05-18: Exercised 39,750 options at $2.25 (acquired; $89,438).
- 2026-05-18: Derivative disposition of 39,750 shares at $0 (reported as M; likely shares surrendered in connection with the exercise).
- Open-market sales:
- 10,000 @ $18.76 (5/18) — $187,600
- 10,000 @ $18.11 (5/18) — $181,100
- 10,000 @ $16.57 (5/18) — $165,700
- 5,000 @ $14.87 (5/18) — $74,350
- 9,358 @ $14.01 (5/19) — $131,106
- 5,617 @ $13.97 (5/19) — $78,469
- Total open-market sale proceeds ≈ $818,325.
- Shares owned after the transactions: not specified in the provided summary — see the full Form 4 for post-transaction holdings.
- Footnotes/plan details: filing shows exercise and a zero-dollar derivative disposition (common when shares are surrendered to cover exercise costs or taxes); no 10b5-1 plan or tax-withholding code explicitly provided in the supplied data.
- Filing timeliness: Report covers 2026-05-18 and was filed on 2026-05-20 (filed within the typical two-business-day reporting window).
Context
- For retail investors: an option exercise is an acquisition event (often viewed as a vote of confidence), but immediate or subsequent sales (as here) can be routine (liquidity, tax payment, or portfolio rebalancing) and do not by themselves indicate company prospects.
- The Form 4 shows both the exercise and substantial open-market sales; read the full filing for exact post-transaction holdings and any issuer disclosures.